Source: Hindu
Disclaimer: Copyright infringement not intended.
India has established its first diabetes biobank to facilitate advanced research on diabetes and its variations particularly those unique to the Indian population.
Feature |
Details |
Purpose |
To advance research on diabetes and its variations with a focus on the Indian population. |
Location |
Madras Diabetes Research Foundation (MDRF), Chennai. |
Collaborators |
Indian Council of Medical Research (ICMR) and MDRF. |
Focus Areas |
Identification of novel biomarkers, early diagnosis and personalized treatment strategies. |
Biospecimens |
Blood samples from individuals with various types of diabetes including Type 1, Type 2 and gestational diabetes. |
Collection, processing, storage and distribution of biospecimens.
Support for scientific studies on diabetes progression and complications.
Enables identification of biomarkers for early diagnosis.
Facilitates personalized treatment approaches.
Supports longitudinal studies to track the progression of diabetes and related complications.
Blood samples from the ICMR Young Diabetes Registry which includes unique cases like Type 1 diabetes and Type 2 diabetes in young individuals.
Samples from gestational diabetes cases in India which show distinct characteristics compared to global trends.
Development of effective prevention strategies tailored to the Indian population.
Better management of diabetes through evidence-based interventions.
Supports the formulation of healthcare policies based on robust data.
Must read article: https://www.iasgyan.in/daily-current-affairs/diabetes-epidemic-in-india
India accounts for one-fourth of the global diabetic population.
A government study covering 1.2 lakh individuals across all states reported a rise in diabetes prevalence.
Unique clinical features of diabetes in Indians such as early onset, require targeted research and management strategies.
Expansion of similar biobank facilities across other regions in India.
Integration with international biobanking networks for global collaborations.
Dissemination of findings to healthcare practitioners for improved clinical practices.
Awareness campaigns for diabetes prevention based on research insights.
Data from the biobank can aid in framing targeted healthcare policies.
Supports the implementation of personalized treatment strategies to combat the diabetes epidemic effectively.
Sources:
PRACTICE QUESTION Q.Discuss the growing burden of diabetes in India and its socio-economic implications. Suggest measures to address this challenge. 250 Words. |
© 2024 iasgyan. All right reserved